{"name":"Torrent Pharmaceuticals","slug":"torrent","ticker":"TORNTPHARM.NS","exchange":"NSE","domain":"torrentpharma.com","description":"Torrent Pharmaceuticals Ltd, d/b/a Torrent Pharma, is an Indian multinational pharmaceutical company, part of the Torrent Group and headquartered in Ahmedabad. It was promoted by U. N. Mehta, initially as Trinity Laboratories Ltd, and was later renamed Torrent Pharmaceuticals Ltd.","hq":"Ahmedabad, India","founded":0,"employees":"17059","ceo":"Aman Mehta","sector":"Cardiovascular / GI / CNS Generics","stockPrice":4029.2,"stockChange":-22.1,"stockChangePercent":-0.55,"marketCap":"$1.4T","metrics":{"revenue":127420899328,"revenueGrowth":17.6,"grossMargin":75.6,"rdSpend":0,"netIncome":22722500608,"cash":7939999744,"dividendYield":0.87,"peRatio":59.9,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2028-06-01","label":"Lisinopril patent cliff ($100.0M at risk)","drug":"Lisinopril","type":"patent_expiry","sentiment":"negative"},{"date":"2029-06-01","label":"Atorvastatin patent cliff ($150.0M at risk)","drug":"Atorvastatin","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"oncology","drugs":[{"name":"Torrent's Donepezil Hydrochloride Tablets 10mg","genericName":"Torrent's Donepezil Hydrochloride Tablets 10mg","slug":"torrent-s-donepezil-hydrochloride-tablets-10mg","indication":"Other","status":"phase_1"},{"name":"Torrent's Felodipine Extended-Release Tablets","genericName":"Torrent's Felodipine Extended-Release Tablets","slug":"torrent-s-felodipine-extended-release-tablets","indication":"Other","status":"phase_1"},{"name":"Daiichi Sankyo Inc's Benicar Tablets 40 mg","genericName":"Daiichi Sankyo Inc's Benicar Tablets 40 mg","slug":"daiichi-sankyo-inc-s-benicar-tablets-40-mg","indication":"Other","status":"phase_1"},{"name":"Forest Pharmaceuticals Inc's Bystolic Tablets","genericName":"Forest Pharmaceuticals Inc's Bystolic Tablets","slug":"forest-pharmaceuticals-inc-s-bystolic-tablets","indication":"Other","status":"phase_1"}]},{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"TRC150094","genericName":"TRC150094","slug":"trc150094","indication":"Type 2 diabetes mellitus","status":"phase_3"}]}],"pipeline":[{"name":"Torrent's Donepezil Hydrochloride Tablets 10mg","genericName":"Torrent's Donepezil Hydrochloride Tablets 10mg","slug":"torrent-s-donepezil-hydrochloride-tablets-10mg","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Torrent's Felodipine Extended-Release Tablets","genericName":"Torrent's Felodipine Extended-Release Tablets","slug":"torrent-s-felodipine-extended-release-tablets","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Daiichi Sankyo Inc's Benicar Tablets 40 mg","genericName":"Daiichi Sankyo Inc's Benicar Tablets 40 mg","slug":"daiichi-sankyo-inc-s-benicar-tablets-40-mg","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Forest Pharmaceuticals Inc's Bystolic Tablets","genericName":"Forest Pharmaceuticals Inc's Bystolic Tablets","slug":"forest-pharmaceuticals-inc-s-bystolic-tablets","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"TRC150094","genericName":"TRC150094","slug":"trc150094","phase":"phase_3","mechanism":"TRC150094 is a selective peroxisome proliferator-activated receptor delta (PPARδ) agonist that enhances insulin sensitivity and lipid metabolism.","indications":["Type 2 diabetes mellitus","Non-alcoholic fatty liver disease (NAFLD)"],"catalyst":""}],"recentEvents":[{"date":"2024-02-14","type":"earnings","headline":"Torrent Pharmaceuticals reports Q3 FY2024 earnings","summary":"Torrent Pharmaceuticals announced its Q3 FY2024 earnings, with revenue growth of 12% year-over-year.","drugName":"","sentiment":"positive"},{"date":"2023-08-01","type":"deal","headline":"Torrent Pharmaceuticals partners with US-based company for generic drug development","summary":"Torrent Pharmaceuticals entered into a partnership with a US-based company to develop and commercialize generic versions of certain pharmaceutical products.","drugName":"","sentiment":"neutral"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi_gFBVV95cUxQZ0lFSjlrZjlJM05qOVZHcWxGRmlQSGxBOVY2N19CYk5OdnpqV3ExM0Y2NTdpbk8wQ2ZYaC1ralktUkw5M3ZzNGdYWjhyOUZtdFBNYndUWW1VX1Q3UGlsMWYzWjYxTU1IVmhJcWpPTHhQN3liUldmNFdrQzY4RWVId0ZtZUR6WHc4S09qNGI2bkM0eHNobXdIOGR3SDM4ejBYVEpYSFI1Tm05YTNPbC00WWVNTzV1RU5rQng5cVg3Rnc2YnZfc0F6TDBPSF9LNWhpU0diMHhlWlp4bm1mMEx3SVF3dmo2VGk4TVV5NnFqaWZPeV9Nb2RxSEs3Y0E4d9IBgwJBVV95cUxQblI2bEVmX2Z0S2ZtTlFsaWMxaGUwTXlRUDVSX1FXR3F3R2ZPeW9NSVE2VHNyMmNwaVFIeE9mWUxUNW5NUTVaX1ZQM1RXWmNINHQ2SG0wUlJKLXVHT19jTE84TTJncjRBWXFVZkJWSjhHN0RRZGR4dnlmdnc3bUFGdE8xY0lYOFMydkJuYzhJejl1azh3bUJCVVM1cDBjOHlHbEZ4VVhQb1ZucVV3QjB2T2laYW5LTzE0ZEptTHAzWHdTd1Bva0xBMlpqZzEycS1FQmJ6MmRMVGJUaDQ5LVlWNmJrUF9CRG5UVS1MRVFEdF96RnltdmNpQ0dBU3NvUjh6Yktn?oc=5","date":"2025-12-03","type":"pipeline","source":"simplywall.st","summary":"If EPS Growth Is Important To You, Torrent Pharmaceuticals (NSE:TORNTPHARM) Presents An Opportunity - simplywall.st","headline":"If EPS Growth Is Important To You, Torrent Pharmaceuticals (NSE:TORNTPHARM) Presents An Opportunity","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTFA3cTVsei02cDVyLXJxZlV4eXdId043c0YtUWpGYkEyVVNqTi1HNTRnczlCNkVhWXFQbmlFWU03VEkzNG1JYzVZYXJXa3FwcWlfd2tEVEQ5YTR1QkZtblBqU2Q5TFFDUWlQaUxkUkc0anJxX2FZX2V6ag?oc=5","date":"2025-11-25","type":"pipeline","source":"Quiver Quantitative","summary":"Xtrackers Nifty 500 India ETF Holdings - Quiver Quantitative","headline":"Xtrackers Nifty 500 India ETF Holdings","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTE5jMkZtVmhnMnNkLTRuQ181YUp2UFdUa0YzRFpBdzFPTmNfWWlMenJIV2RrVXFXOVJaVEZnYWtYeFFabkd5RGlyZXVoV2VDS0FxemV3MGRhTFVrVUh1a3VvVkZMODhJYUI5a2tGSw?oc=5","date":"2025-04-09","type":"pipeline","source":"Quiver Quantitative","summary":"iShares MSCI India ETF Holdings - Quiver Quantitative","headline":"iShares MSCI India ETF Holdings","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiaEFVX3lxTFAzbkNNUkFQYlB5S21oeVFvbjNDTjJkeWRqTHFkWlJkNTByMVhuNExxdEZyNTVyMl96Rm1RN1dGWDRScHR2bktFRUl1NEIzU25KYVZjWWo0NmNJREUwdFJEdmQ5eHRsZDIy?oc=5","date":"2018-08-28","type":"pipeline","source":"Yahoo Finance UK","summary":"Torrent Pharmaceuticals Limited (TORNTPHARM.BO) company profile and facts - Yahoo Finance UK","headline":"Torrent Pharmaceuticals Limited (TORNTPHARM.BO) company profile and facts","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTE4ta1Y1WnNPcjA3ckwyRnFqUS11ekVaczNTWXdqclRHMXNjZ3dvS0gtYUl5YUlNS2hybHdWWlQ0Slpkd2JkVVRtZV9waG1nWkZZbTd0bXlSWTBsdXRIWUE?oc=5","date":"2018-07-13","type":"pipeline","source":"Yahoo Finance UK","summary":"Abbott India Limited (ABBOTINDIA.NS) stock price, news, quote and history - Yahoo Finance UK","headline":"Abbott India Limited (ABBOTINDIA.NS) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTE0wNFJ4bTl3dlZYdnBiSklRRExCRU1xa3lFSG5DRkhGNy1JaHU0QkRsWC1YVUhGeVFFTDU4bVo1RldVWXF1cGd4MFRUWS1hLXk2TGVDTEl3N1dMa0FyVWc?oc=5","date":"2017-08-24","type":"pipeline","source":"Yahoo Finance Singapore","summary":"Abbott India Limited (ABBOTINDIA.NS) stock price, news, quote and history - Yahoo Finance Singapore","headline":"Abbott India Limited (ABBOTINDIA.NS) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTE5UbFlSTVU4d0ViZVVIOE5uT2NVdWxTUVc5TVdrS19HRk9LaExTZUJ2RG1KbDQxLTZETlQydUlfR2s0SnBNM2tQckpNMGEyeEphRHo2LXJGWV8yeE1tN2c?oc=5","date":"2017-08-08","type":"pipeline","source":"Yahoo Finance Singapore","summary":"Ajanta Pharma Limited (AJANTPHARM.NS) stock price, news, quote and history - Yahoo Finance Singapore","headline":"Ajanta Pharma Limited (AJANTPHARM.NS) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWkFVX3lxTE94dTB2bUlQRGp3bWlkS0dmN1VwVXI4OXpFaVdyUTNxaHc5TEtMSjFVM1R5clpPRmZHRXA0OTRFX2EyaHlwOENiUzlzdWJQR3Z6eDIyX1VydkNIdw?oc=5","date":"2017-06-07","type":"pipeline","source":"Yahoo Finance Singapore","summary":"Ipca Laboratories Limited (IPCALAB.NS) stock price, news, quote and history - Yahoo Finance Singapore","headline":"Ipca Laboratories Limited (IPCALAB.NS) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTE84ZDFCRlVxRGtXWTZzQ1JiY1UyTjRTV0VyRTlpdU9zSjh3cFhDN1g1LUl3MU9sU1lCMzhSZUNncW9JRjQ0d2d5Q3JSc3gyM0tNek1yLUxyb010U1VETFE?oc=5","date":"2017-05-20","type":"pipeline","source":"Yahoo Finance UK","summary":"Torrent Pharmaceuticals Limited (TORNTPHARM.NS) stock price, news, quote and history - Yahoo Finance UK","headline":"Torrent Pharmaceuticals Limited (TORNTPHARM.NS) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTE9kbWN1aGxhS0h6SkNxZFlJLUl1VldUOWZQU042X0FKRUJNU2NKN0x1V012a3d1RDRMMUxUQmlWMHNBX0lPZEhNQ25EUmNzUkkzTVYwaDRqMmkwaHBxa1E?oc=5","date":"2017-05-20","type":"pipeline","source":"Yahoo Finance Singapore","summary":"Wockhardt Limited (WOCKPHARMA.NS) stock price, news, quote and history - Yahoo Finance Singapore","headline":"Wockhardt Limited (WOCKPHARMA.NS) stock price, news, quote and history","sentiment":"neutral"}],"patents":[{"drugName":"Lisinopril","drugSlug":"lisinopril","patentNumber":"","type":"Patent Cliff","expiryDate":"2028-06-01","territory":"US","annualRevenue":100000000},{"drugName":"Atorvastatin","drugSlug":"atorvastatin","patentNumber":"","type":"Patent Cliff","expiryDate":"2029-06-01","territory":"US","annualRevenue":150000000}],"drugCount":5,"phaseCounts":{"phase_1":4,"phase_3":1},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Cipla","Sun Pharma","Aurobindo Pharma"],"therapeuticFocus":["Cardiovascular","Gastrointestinal","CNS"],"financials":null,"yahoo":{"currentPrice":4029.2,"previousClose":4051.3,"fiftyTwoWeekHigh":4482.9,"fiftyTwoWeekLow":3101.6,"fiftyTwoWeekRange":"3101.6 - 4482.9","fiftyDayAverage":4204.08,"twoHundredDayAverage":3800.04,"beta":0.19,"enterpriseValue":1390858338304,"forwardPE":65,"priceToBook":16.15,"priceToSales":10.7,"enterpriseToRevenue":10.91,"enterpriseToEbitda":33.9,"pegRatio":0,"ebitda":41027276800,"ebitdaMargin":32.2,"freeCashflow":0,"operatingCashflow":0,"totalDebt":28220000256,"debtToEquity":33.4,"currentRatio":0,"returnOnAssets":0,"returnOnEquity":0,"analystRating":"1.7 - Buy","recommendationKey":"buy","numberOfAnalysts":29,"targetMeanPrice":4519.59,"targetHighPrice":5100,"targetLowPrice":3876,"dividendRate":35,"payoutRatio":0.48,"fiveYearAvgDividendYield":1.05,"exDividendDate":1771372800,"insiderHeldPercent":71.1,"institutionHeldPercent":14.8,"sharesOutstanding":338445440,"floatShares":103941076,"sharesShort":0,"shortRatio":0,"shortPercentOfFloat":0,"epsTrailing":67.25,"epsForward":62.02,"revenuePerShare":376.39,"bookValue":249.47,"officers":[{"age":null,"name":"Mr. Aman  Mehta","title":"MD & Whole-Time Director"},{"age":53,"name":"Mr. Sudhir  Menon CA, CWA","title":"Executive Director of Finance & CFO"},{"age":57,"name":"Mr. Ashish  Hajarnish M.Pharm","title":"Executive Director of Operations"},{"age":null,"name":"Ms. Geena V. Malhotra","title":"Chief Technology Officer"},{"age":null,"name":"Mr. Chintan M. Trivedi","title":"Company Secretary & Compliance Officer"},{"age":72,"name":"Mr. Jaydip  Bhatt","title":"Vice President of Human Resource"},{"age":null,"name":"Mr. Abdullah Salam Said Al Abri","title":"Chief Customer Service Officer"},{"age":null,"name":"Mr. Sanjay  Gupta","title":"President and CEO of Torrent Pharma USA"}],"industry":"Drug Manufacturers - Specialty & Generic","irWebsite":"","website":"https://www.torrentpharma.com","phone":"91 79 2659 9000"}}